Prepandemic characteristics for the 104 dyads (persons with dementia and informal carers, n)
| N=104 | |
| Person with dementia | |
| Age, mean (SD) | 82 (7) |
| Female gender, n (%) | 63 (61) |
| Residency | |
| Living alone, n (%) | 46 (44) |
| Coresiding with the reporting informal carer, n (%) | 46 (44) |
| Coresiding with someone else than the informal carer, n (%) | 12 (12) |
| Dementia aetiology | |
| Alzheimer’s disease, n (%) | 45 (43) |
| Vascular dementia, n (%) | 6 (6) |
| Dementia in other diseases classified elsewhere, n (%) | 10 (10) |
| Unspecified dementia, n (%) | 43 (41) |
| MMSE, range 0–30, median (IQR) | 21(18–24) |
| FAST, range 1–7, median (IQR) | 4 (4–4) |
| GMHR, range 1–4, median (IQR) | 3 (2–3) |
| PSMS, range 6–30, median (IQR) | 11 (9–14) |
| IADL, range 8–31, median (IQR) | 22 (18–27) |
| Drugs in general | |
| Total number, median (IQR) | 6 (4–8) |
| Regularly, median (IQR) | 5 (3–7) |
| Psychotropic drugs | |
| Total no, median (IQR) | 1 (0–2) |
| Regularly, median (IQR) | 1 (0–1) |
| Antipsychotic drugs (N05A), n (%) | 6 (6) |
| Anxiolytic drugs (N05B), n (%) | 3 (3) |
| Hypnotic/sedative drugs (N05C), n (%) | 10 (10) |
| Antidepressant drugs (N06A), n (%) | 19 (18) |
| Antidementia drugs (N06D), n (%) | 52 (50) |
| On-demand, median (IQR) | 0 (0–0) |
| Antipsychotic drugs (N05A), n (%) | 0 (0) |
| Anxiolytic drugs (N05B), n (%) | 5 (5) |
| Hypnotic/sedative drugs (N05C), n (%) | 12 (12) |
| Antidepressant drugs (N06A), n (%) | 0 (0) |
| Antidementia drugs (N06D), n (%) | 0 (0) |
| Volunteering services, n (%) | 8 (8) |
| Healthcare services | |
| Daily home nursing, n (%) | 52 (50) |
| Weekly day care, n (%) | 29 (28) |
| Respite care (In-home and out-of-home), n (%) | 2 (2) |
| Informal carer | |
| Age, mean (SD) | 65 (12) |
| Female gender, n (%) | 68 (65) |
| Kinship to the person with dementia | |
| Spouse, n (%) | 44 (42) |
| Child, n (%) | 58 (56) |
| Others, n (%) | 2 (2) |
Drugs were classified by the Anatomical Therapeutic Chemical Index; antipsychotics, anxiolytics, hypnotics/sedatives, antidepressants and antidementia drugs constituted psychotropic drugs.
FAST, Functional Assessment Staging; GMHR, General Medical Health Rating Scale; IADL, Instrumental Activities of Daily Living Scale; ICD-10, International Classification of Diseases10th version; MMSE, Mini-Mental Status Examination; Prepandemic, Six-month assessment of parent trial (12 December 2019 to 11 March 2020); PSMS, Physical Self-Maintenance Scale.